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Summary
Background: Paraquat is a herbicide with a good
occupational safety record, but a high mortality
after intentional ingestion that has proved refractory
to treatment. For nearly three decades paraquat
concentration–time data have been used to
predict the outcome following ingestion. However,
none of the published methods has been indepen-
dently or prospectively validated. We aimed to use
prospectively collected data to test the published
predictive methods and to determine if any is
superior.
Methods: Plasma paraquat concentrations were
measured on admission for 451 patients in 10
hospitals in Sri Lanka as part of large prospective
cohort study. All deaths in hospital were recorded;
patients surviving to hospital discharge were fol-
lowed up after 3 months to detect delayed deaths.
Five prediction methods that are based on paraquat
concentration–time data were then evaluated in all
eligible patients.
Results: All methods showed comparable perfor-
mance within their range of application. For
example, between 4- and 24-h prediction of
prognosis was most variable between Sawada and
Proudfoot methods but these differences were
relatively small [specificity 0.96 (95% CI:
0.90–0.99) vs. 0.89 (0.82–0.95); sensitivity 0.57 vs.
0.79, positive and negative likelihood ratios 14.8 vs.
7.40 and 0.44 vs. 0.23 and positive predictive
values 0.96 vs. 0.92, respectively].
Conclusions: All five published methods were better
at predicting death than survival. These predictions
may also serve as tools to identify patients who need
treatment and for some assessment to be made of
new treatments that are trialled without a control
group.
Background
Paraquat (1,1’-dimethyl-4,4’-bipyridinium) dichlor-
ide is a non-selective contact herbicide that has
been widely used in many countries since the
1960s. It is fast-acting, rain-fast and facilitates
‘no-till’ farming, but it has attracted controversy
because of a high mortality in cases of self harm
(typical case fatality 50–90%).1 It is a common
cause of lethal poisoning in some developing
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countries in Asia, Pacific Islands and the
Caribbean.2 Ingestion of >20ml of a 20% prepara-
tion is likely to cause death from multi-organ failure
and cardiogenic shock within 1–4 days, while
smaller quantities (10–20ml) may initiate an irre-
versible lung fibrosis and renal failure resulting in
death within several weeks.1 Current treatments for
paraquat poisoning focus on reducing absorption
from the gastrointestinal tract and increasing its
elimination.1 Several other interventions have been
proposed but none has been shown to be effective
in clinical trials. The most promising is ‘immuno-
suppressive’ therapy, but this is not widely used due
to the lack of evidence supporting its use.3
A reliable predictor of prognosis would be helpful
to guide treatment and future clinical research on
antidotes and other therapies. For example, early
prediction of inevitable death would be important to
stop inappropriate treatments in terminal acute
paraquat poisoning patients.4 A tool to identify
patients who will die from the delayed onset of
lung fibrosis might be useful to identify patients most
likely to benefit from antidotes directed at prevent-
ing lung injury or fibrosis.3
The measurement of plasma paraquat concentra-
tion has considerable support as a marker of severity
and prognosis. Proudfoot et al.5 produced a
nomogram in 1979 that related the outcome to the
plasma paraquat concentration on admission and
the time from ingestion to blood collection. In 1987,
Scherrmann extended the Proudfoot nomogram so
that it was applicable to patients who presented
>24h after ingestion.6 Hart et al.7 created six
concentration–time curves to represent estimates of
the probability of survival ranging from 10 to 90%.
Sawada et al.8 developed a Severity Index for
Paraquat Poisoning (SIPP) to predict which patients
would die and whether the patient would die from
acute organ failure or lung fibrosis. In 1999, using
multiple logistic regression of published data, Jones
et al.4 produced a calculation using concentration
and time to give a numeric estimate of the
probability of survival (Table 1). The largest and
most recently published study by Gil et al.9
demonstrated a very strong relationship between
measured concentrations and survival without
sequelae but unfortunately did not validate previous
measures nor propose a new method of using
plasma concentrations to predict outcome.
Thus, paraquat concentration–time data have
been used to predict outcome for nearly
three decades. However, no method has been
Table 1 Nomograms and prognostic formula for prediction of outcome with paraquat concentrations
References Location Patients Prognostic formula for survival Validated
by authors
Limitations in
application
Proudfoot et al.5 UK:
London,
Edinburgh,
Scotland
71 Patients with paraquat levels less
than a line connecting concentra-
tions of 2.0, 0.6, 0.3, 0.16 and
0.1 mg/ml at 4, 6, 10, 16 and
24 h survive.
No Applicable only
between 4 and 24 h.
Hart et al.7 UK 219 Graph plasma paraquat levels vs.
time since ingestion. Generating
contour map lines denoting equal
probability of survival.
No Applicable up to 28 h.
Nomogram unable to
assign risk to concentra-
tions taken <4 h which
are > 5.5 mg/ml.
Scherrmann et al.6 France 30 Survivors have plasma paraquat
levels less than C mg/ml where
C=1/(0.471 (h since ingestion)
1.302)
No Curve is used to extend
Proudfoot for use
beyond 24 h.
Applicable >4h.
Sawada et al.8 Japan 30 SIPP = time to treatment (h) serum
PQ concentration (mg/ml) SIPP< 10
predicts survival SIPP 10–50 death
from lung fibrosis, SIPP > 50 death
from circulatory failure.
No Applicable up to 200 h.
Jones et al.4 Review of
worldwide
literature
375 Probability of survival = exp(logit)/
[1 + exp(logit)]
Logit = 0.58[2.33 log10 (plasma
paraquat mg/ml)] [1.15 log10
(h since ingestion)]
No Applicable up to 200 h.
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prospectively validated in a large cohort study nor
have their predictive values been compared.
We have used data from patients prospectively
enrolled in a cohort study in Sri Lanka to test the
accuracy of previously published methods of pre-
dicting outcome, and to determine if any were
superior.
Methods
Patients and setting
We obtained plasma samples for quantification from
451 patients ingesting paraquat while we conducted
two other studies in 10 different Sri Lankan hospitals
between April 2002 and January 200610,11 (see
Appendix 1: Recruitment flow diagram). These
studies were both approved by a number of Sri
Lankan and overseas Ethical Review Committees.
These studies included 809 patients with paraquat
poisoning but 13 were lost to follow up and a further
358 either did not have a paraquat concentration
measured or the time of ingestion or measurement
was not known or not recorded.
Blood was taken from patients on admission, or if
this did not occur, during the patient’s first day in
hospital. The sample was centrifuged, before the
plasma was taken off and immediately stored at
208C until analysis. Plasma samples were sent to
the Syngenta CTL (Alderley Park, Macclesfield,
Cheshire, UK) for quantitative analysis using
HPLC, LC–MS–MS and LC fluorescence.12 The
three techniques have different LoQs; the most
sensitive is LC–MS–MS, and this was done when
other methods did not detect paraquat. A UV
detector was used in tandem with a fluorescence
detector to measure very high levels of paraquat,
and a proportion of the samples measured by
fluorescence were also analysed by LC–MS–MS to
confirm that the methods gave very similar results.
Clinical data on patients were prospectively
recorded in all hospitals, in particular, whether
death occurred in hospital and the time to death. All
patients who survived to discharge were visited after
3 months to determine if there were any delayed
deaths.
Method of validating nomograms
Five methods to predict outcome were evaluated.4–8
We constructed nomograms from the SIPP score
calculations of Sawada et al. and the probability
score of Jones in order to provide a graphical
representation of these prediction tools for visual
comparison with the other methods (Figure 1).
The five methods are applicable over a different
range of times. Proudfoot’s nomogram can only be
applied to levels taken between 4 and 24h. Hart’s
nomogram is also difficult to apply outside these
times. Thus, we could directly compare the
Proudfoot, Hart, Sawada and Jones methods on
samples from patients whose plasma paraquat levels
were taken between 4 and 24 h (Comparison 1). The
methods of Scherrmann, Sawada and Jones could be
compared for all patients who had plasma paraquat
levels measured at least 4 h after ingestion
(Comparison 2).
To calculate sensitivity and specificity
2 2 tables were constructed (together with 95%
CIs). Sensitivity is defined as the proportion of
people who died that were predicted to die, and
specificity as the proportion of people who survived
that were predicted to survive.13 The positive
predictive value is the proportion of those predicted
to die who died, and the negative predictive value is
the proportion of those predicted to survive who did
so. Positive likelihood ratio is the ratio of the
likelihood of death in those with a positive test vs.
those with a negative test. Negative likelihood ratio
is the ratio of the likelihood of death in those with a
negative test vs. those with a positive test. All
calculations were performed using Graph Pad Prism
v 4.0. The Jones and Hart methods for predicting
outcome provide varying estimates of risk (very low
to moderate to very high). For the Jones equation
and Hart nomogram, the line denoting an equal
probability of survival or death (50%) was used as
the cut off line to create the 2 2 table for direct
comparison of test performance with the other
methods.
The overall performance of the methods for
predicting the mortality of the entire cohort (com-
pared to the actual mortality) was also examined.
For the Sawada, Proudfoot and Scherrmann meth-
ods, this was done by simply counting every person
to whom the method could be applied with a
concentration above the line as an expected death.
For the Jones and Hart methods, we added the
expected probability for each individual to provide
an overall estimate for the whole cohort.
The formulation of paraquat in Sri Lanka was
changed in August 2004 to a new product that was
developed to decrease toxicity through a reduction
in the amount of paraquat absorbed from the
gastrointestinal tract following ingestion.14 Since
Tmax values were similar between the two formula-
tions in laboratory studies, we did not expect the
nomograms to be affected by variation in formula-
tion ingested. However, to test this hypothesis, we
compared data from those ingesting old and new
formulations to see if test performance varied with
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formulation. We had previously noted that gastric
lavage may adversely affect outcome,15 and postu-
lated it might alter the performance of the methods.
To test this hypothesis, we compared data from a
subset of 392 patients that we had recorded the
treatment provided to see if test performance varied
by whether gastric lavage had been performed.
We also, post hoc, performed a logistic regression
of log transformed data to derive a formula that
would best have predicted the survival of our
population.
Results
Demographic data from the Sri Lankan patients are
compared with demographic data from the previous
studies in Table 2. The Sri Lankan patients were
younger but had a similar gender balance. Reliable
information on treatment was available on the 392
patients from the formulation study.10 The most
frequent were Fullers’ earth (76.5%; 300/392), and
activated charcoal (22.4%; 88); 15.6% (61) received
both treatments. Other gastrointestinal decontami-
nation was also common: 12.0% (47) had forced
emesis and 61.5% (241) had gastric lavage. Ninety
patients (23.0%) were given immunosuppressive
treatments and from that group, 11.7% (46) received
cyclophosphamide, 11.2% (44) received predniso-
lone and 2.0% (8) were given both treatments. No
patients had haemodialysis. The overall survival rate
of 39% in our cohort was comparable to the
30–62% rates observed in the previous studies.
There were no statistically significant differences
between old and new formulations in specificity and
sensitivity of any method (data not shown).
Therefore, these groups were combined for all
subsequent comparisons.
The median time from ingestion to blood sam-
pling was 11 h with IQR 4.5–26 h (range 20min to
335 h). Four samples were taken <1 h and 66< 4h
post ingestion. The plasma concentrations of
patients who lived and died are shown together
with the nomogram prediction lines in Figures 1 and
2. It can be seen in Figure 1 that most patients were
not near the cut off lines and the use of different
methods would change the predicted outcome of
only a minority of patients. A higher proportion of
the < 4h samples incorrectly predicted death or
survival (Figure 1). In order to directly compare test
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Figure 1. Paraquat concentrations and outcome of patients with paraquat poisoning and Jones, Proudfoot, Scherrmann and
Sawada prediction lines. All methods predict those above the lines are more likely to die than survive (filled bullet = death,
bullet = alive).
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performance on the same patients, some patients
needed to be excluded. There were 451 patients in
the cohort but only 385 patients had blood levels
taken at least 4 h after ingestion. These 385 patients
were used for the comparison of the Jones, Sawada
and Scherrmann methods (Comparison 2). One
hundred and twenty patients had blood samples
more than 24 h after ingestion, therefore 265
patients were used for the direct comparison of
Proudfoot, Hart, Sawada and Jones methods
(Comparison 1).
In Comparison 1, the methods of Proudfoot, Hart,
Sawada and Jones showed comparable perfor-
mance. Specificity varied between 0.96 and 0.89
and sensitivity varied between 0.79 and 0.57.
Positive predictive values (0.92–0.96) were much
better than negative predictive values (0.59–0.73)
for all methods (Table 3). Similar overlapping
measures of performance were found in
Comparison 2 of the Scherrmann, Sawada and
Jones methods for all patients with plasma paraquat
levels after 4 h (Table 4). There was also no
significant change in test performance when all
451 patients were analysed using the methods of
Sawada and Jones (Appendix 2).
All methods under-estimated the actual number of
deaths in our cohort (Table 5). Gastric lavage
appeared to adversely affect the performance of all
methods but the effect was particularly noted in
methods using samples taken at <4h (Table 6). This
was reflected in a substantially lower negative
predictive value in those who had received gastric
lavage. The risk of death was also much further
under-estimated in these patients (Table 6).
Our post hoc logistic regression of log-trans-
formed data derived the following probability
formula:
Probability of survival ¼ expðlogitÞ½1þ expðlogitÞ
Logit = 0.701+ [1.739 log10 (plasma paraquat mg/
ml)] + [0.896 log10 (h since ingestion)].
This did not change by more than a few percent if
the samples taken <4h from the time of ingestion
were excluded. However, when the probabilities
were dichotomized to provide a simple line
predicting death or survival (Appendix 3), this
lower line did not perform much better in terms of
clinical prediction for individuals. The better sensi-
tivity (90%) was offset by lower specificity (74%)
and the positive likelihood ratio was only 3.37.
Figure 2. Paraquat concentrations and outcome from
277 patients (up to 28-h post ingestion) with paraquat
poisoning compared with the probability of survival
estimated by Hart’s nomogram. (filled bullet = death,
bullet = alive).
Table 2 Demographic data reported in original studies and in the present cohort
Proudfoot Hart Scherrmann Sawada Jones This study
Total Patients 73 219 30 30 375 451
Female 29 NA 8 11 101
Male 42 NA 22 19 350
Age NA
Mean 38 – 45 38.3 29
Median – – – 25
Range (IQR) 16–81 17–75 – 1–87 12–93 (20–34)
Post ingestion time
to blood sampling
NA NA
Median – 11
Range (IQR) 24–360 h 0.5–335 (4.5–26.0)
Number surviving 45 (62%) 109 (49.7%) 9 (30%) 10 (33%) 134 (35.7%) 186 (39.6%)
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Discussion
These results demonstrate that previously published
methods to predict a fatal outcome after paraquat
poisoning patients using plasma paraquat concen-
trations are reasonably accurate in predicting death
for individuals with paraquat poisoning. However,
they all had much better specificity than sensitivity.
The good predictive utility of the measured
paraquat concentration is to be expected from the
predictable and steep dose-related increase in
toxicity. It is therefore valuable to consider why
some patients were misclassified. Limited human
data suggest that peak plasma concentrations after
paraquat ingestion occur within 2–4 h with a
distribution half life of 5 h.16 It is therefore likely
that plasma paraquat concentrations taken later (at
least 4 h) give a better estimate of the total amount of
paraquat that has reached the systemic circulation.
Four patients survived with a high plasma paraquat
concentration within 2–4 h after ingestion; it is likely
that these preceded significant distribution. A few
patients died with low plasma paraquat concentra-
tions taken within 2–4 h. It is likely that further
absorption took place after these blood samples
were taken.
Patients misclassified after 4 h may have been
atypical. Some may have had a total systemic
exposure to paraquat that was greater or less than
expected due to the rate of renal paraquat clearance
after the blood sample was taken. This might be due
to variable pre-morbid renal function and also
Table 5 Comparison of the different methods in terms of estimated total mortality and actual mortality in a Sri Lankan
cohort of patients
Method Patients to which
prognostic method
could be applied (n)
Estimated mortality
within valid range (%)
Actual
mortality (%)
Jones et al. 451 45.8 60.3
Sawada et al. 451 40.4 60.3
Proudfoot/Scherrmann 385 55.5 58.4
Proudfoot et al. 265 52.5 61.1
Hart 277 50.2 61.7
Table 3 Comparison of prediction of outcome by four methods in 265 patients with paraquat concentrations between
4- and 24-h post ingestion
Method Specificity
(95% CI)
Sensitivity
(95% CI)
Positive
likelihood
ratio
Negative
likelihood
ratio
Positive predictive
value (95% CI)
Negative predictive
value (95% CI)
Proudfoot et al. 0.89 (0.82–0.95) 0.79 (0.72–0.85) 7.40 0.23 0.92 (0.86–0.96) 0.73 (0.64–0.81)
Hart et al. 0.92 (0.85–0.97) 0.77 (0.69–0.83) 9.78 0.25 0.94 (0.88–0.97) 0.71 (0.63–0.79)
Sawada et al. 0.96 (0.90–0.99) 0.57 (0.49–0.65) 14.78 0.44 0.96 (0.90–0.99) 0.59 (0.51–0.67)
Jones et al. 0.93 (0.87–0.97) 0.70 (0.63–0.77) 10.35 0.32 0.94 (0.88–0.98) 0.67 (0.58–0.74)
Table 4 Comparison of prediction of outcome by three methods in 385 patients with paraquat concentrations more than
4-h post ingestion
Method Specificity
(95% CI)
Sensitivity
(95% CI)
Positive
likelihood
ratio
Negative
likelihood
ratio
Positive predictive
value (95% CI)
Negative predictive
value (95% CI)
Proudfoot/
Scherrmann
0.83 (0.76–0.86) 0.81 (0.76–0.86) 4.82 0.22 0.87 (0.82–0.91) 0.76 (0.69–0.82)
Sawada et al. 0.93 (0.87–0.96) 0.58 (0.51–0.64) 7.70 0.46 0.92 (0.86–0.96) 0.61 (0.54–0.67)
Jones et al. 0.92 (0.87–0.96) 0.66 (0.60–0.72) 8.15 0.37 0.92 (0.87–0.96) 0.66 (0.59–0.72)
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variable treatments (amount of intravenous fluids) or
extent of renal toxicity. Deaths in patients with low
plasma paraquat concentrations may relate to
individual susceptibilities (older, other co-morbid
conditions). In the recent study of a new paraquat
formulation10 age over 50 was an independent
factor adversely affecting outcome (J. Tomenson,
unpublished results), akin to our finding with yellow
oleander (Thevetia peruviana) poisoning.17
There may also have been a contribution to death
from factors other than paraquat toxicity such as
complications of treatment. For example, gastric
lavage might have led to aspiration, asphyxia15 or
to mediastinal perforation,18 while oxygen therapy
may have contributed to free radical damage and
lung damage leading later to fibrosis. The adverse
effect of gastric lavage on the sensitivity of
nomogram negative predictive values and overall
mortality (Table 6) might be seen to suggest that
lavage is contributing to deaths in patients with low
concentrations, however, it is likely to be con-
founded by other prognostic factors and might also
reflect an effect on the pharmacokinetics of para-
quat. We have elsewhere attempted to directly
address whether gastric lavage leads to benefit or
harm after paraquat poisoning,19 but did not find a
consistent or large effect. Nevertheless, these data
provide further cause for concern about the use of
gastric lavage in paraquat poisoning, as it may
interfere with prediction of outcome and cause
adverse events and the evidence to date does not
suggest a benefit is likely.19
It is also possible that the patients used to create
the published nomograms represent atypical popu-
lations with better than usual survival due to
selective reporting. We collected timed (and there-
fore valuable) samples from 60% of our patients,
and the mortality in those who did not have
timed samples taken was higher (77.1% vs.
60.3%—Appendix 1). This problem may have
been even more of an issue in the selection of
patients when the nomograms were derived but the
data on the outcome of the total group from which
patients were selected were not presented in any of
the original studies. Sri Lankan patients themselves
may also be different, for example, due to the short
time to presentation to hospital. More than 50% of
poisoned patients present to a primary care hospital
within 2 h of ingestion20 (they were then usually
referred on to larger hospitals such as those included
in our study). There are no details on the time to
presentation in any of the original studies (Table 1).
In any case it is clear that all methods substantially
underestimated the overall mortality of eligible
patients from our unselected cohort of Sri Lankan
patients.T
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Our study is the largest cohort study of paraquat
poisoning published; however, it is still not large
enough to evaluate the estimates of gradations of
risk set out in the Jones equation and the Hart
nomogram. Only 123 of the 277 (44.4%) patients
(Table 5) that could be evaluated by the Hart
nomogram had an estimated risk of death between
10% and 90%. The Jones equation similarly only
assigned less than half the patients [223/451
(49.4%)] to an estimated risk of death in this
range. However, the underestimate of total mortality
by these two methods (Table 5) was comparable to
other methods and suggests that they are no more
accurate. As most patients do not lie close to the cut
off points, a much larger total number of patients
would be required to determine if specific Hart risk
groups between 10% and 90% were accurate to
within 5% or to demonstrate whether the small
5–10% differences in sensitivity and specificity we
observed between methods was due to chance or
not.21 However, given the overall underestimate of
mortality it is unlikely that any of these methods
would be the optimal method of prediction of the
expected mortality of a cohort.
Prediction may serve a number of purposes. From
a clinical perspective it can identify patients who are
very likely to survive, where prolonged monitoring
or treatment would not be warranted. Conversely, if
rapidly available, it might identify patients whose
outcome is hopeless so that they may be spared
futile life-prolonging measures which have the
potential to cause discomfort, such as extracorpor-
eal elimination techniques (e.g. haemodialysis).
While these concentrations will give considerable
guidance in these decisions, our analysis suggests
that they should not be regarded as accurate enough
to give such reassurance for life and death decisions.
From a research perspective, patients between
those two extremes are those most appropriate to
enrol in clinical trials of new treatments. In addition,
an accurate method of predicting outcome from
paraquat concentrations might allow some estimate
to be made of the effectiveness of new treatments
that have been studied without a control group. Our
study suggests that a plasma paraquat concentration
is not sufficiently predictive to infer effectiveness
from case reports. However, effectiveness of a new
treatment (other than those designed to reduce
absorption) might be inferred by much higher
survival rates in a large unselected cohort with
concentrations predicting death by any method.
Supplementary Data
Supplementary data are available at QJM online.
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